NASDAQ$NEOG

Neogen Corporation · Q4 2025 earnings

Q4 2025 earnings · · Before market open · Investor relations

Briefing

Neogen reported Q4 2025 revenue of $225.5 million with a net loss of $612.2 million driven by a large goodwill impairment.

Neogen Corporation announced results for the fourth quarter ended May 31, 2025, showing revenue of $225.5 million, down 4.8% year-over-year, with core revenue declining 2.9%. The company recorded a net loss of $612.2 million, or $(2.82) per share, primarily due to a $597.9 million non-cash goodwill impairment charge, while adjusted net income was $11.3 million, or $0.05 per share. Adjusted EBITDA was $40.6 million at an 18.0% margin, reflecting softer end-market conditions and integration-related costs.

  • Q4 revenue totaled $225.5 million, a 4.8% decline from the prior year, with core revenue down 2.9%.
  • Net loss reached $612.2 million due to a $597.9 million goodwill impairment; adjusted net income was $11.3 million ($0.05 per share).
  • Food Safety segment revenue was $161.8 million and Animal Safety was $63.6 million, both down year-over-year.
  • Full-year revenue was $894.7 million with adjusted EBITDA of $184.2 million; FY2026 guidance projects revenue of $820-840 million.

Headline financials

Total Revenue

$225M

Previous: $237M-4.8%
EPS (adj)

$0.05

Previous: $0.10-50.0%
Gross Margin

41.2%

No prior period
Adjusted EBITDA Margin

18.0%

Previous: 22.4%-19.6%
Core Revenue Growth

-2.9%

No prior period
Net Income

-$612M

Previous: -$5.4M-11237.0%
Operating Income

-$611M

Previous: $13M-4787.0%
Gross Profit

$92.9M

Previous: $113M-18.2%
Cash & Equivalents

$129M

No prior period

Revenue & EPS history

Neogen · Revenue · Quarterly

$225M

Q4 2025-4.8%vs Q4 2024
Beat estimate in 10 of 15 quarters(67%)
ActualEstimate

Revenue by segment

Neogen · $225M total across 2 segments · Q4 2025

  • Food Safety
    $162M
  • Animal Safety
    $63.6M

Forward guidance

The company initiated FY2026 outlook with revenue expected between $820 million and $840 million and adjusted EBITDA of $165 million to $175 million, reflecting continued end-market weakness and excluding the divested Cleaners & Disinfectants business.

Tailwinds

  • Capital expenditures expected to decline significantly to approximately $50 million.
  • Lower level of inventory write-offs anticipated.
  • Favorable regulatory backdrop in the US for food safety.

Headwinds

  • Continued end-market weakness expected.
  • Negative impact from sample collection production inefficiencies and tariffs.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 19 quarterly earnings reports · overlaid with Q4 2025

Historical avgQ4 2025

-1.6%

Avg return

Earnings day

-2.7%

Avg return

5 days after

-1.6%

Avg return

30 days after

35%

23 / 65 earnings

Positive

+31.5%

Q2 2026

Best reaction

-28.7%

Q3 2025

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q4 2026
Q3 2026+3.9%-7.1%-12.5%
Q2 2026+31.5%+24.5%+46.3%
Q1 2026+16.4%+1.5%+10.0%
Q4 2025-10.9%-14.0%+6.1%
Q3 2025-28.7%-23.3%-15.2%
Q2 2025-3.3%-13.1%-20.7%
Q1 2025-2.8%-0.8%+9.3%
Q4 2024-1.6%-5.3%-1.0%
Q3 2024-13.1%-13.9%-13.6%
Q2 2024-5.5%-8.4%-18.0%
Q1 2024-11.7%-8.8%-11.0%
Q4 2023+2.3%+0.0%+0.8%
Q3 2023+0.2%-3.6%-6.9%
Q2 2023+5.1%+11.2%+30.3%
Q1 2023-1.0%-4.1%-12.2%
Q4 2022+8.0%+7.5%-2.8%
Q3 2022-7.4%-5.3%-15.3%
Q2 2022+1.4%+0.2%-19.2%
Q1 2022+3.0%+6.1%+2.9%
Q4 2021+0.2%-1.9%-3.6%
Q3 2021+3.0%+5.6%+14.9%
Q2 2021+1.2%+0.5%+3.8%
Q1 2021+0.2%+1.1%-4.3%
Q4 2020-4.0%-4.0%-2.9%
Q3 2020-5.3%-1.2%+8.1%
Q2 2020-5.4%-5.7%+1.2%
Q1 2020-10.6%-13.0%-13.1%
Q4 2019+9.0%+10.6%+13.2%
Q3 2019-8.3%-5.2%-4.4%
Q2 2019-8.1%-10.7%+2.4%
Q1 2019-17.8%-19.3%-30.4%
Q4 2018+1.5%+1.7%+3.9%
Q3 2018-4.2%+1.0%+7.6%
Q2 2018-0.8%-0.7%-1.8%
Q1 2018-4.4%-1.5%+6.4%
Q4 2017-2.2%-1.8%-4.5%
Q3 2017-5.9%-6.7%-9.8%
Q2 2017+3.8%+5.6%+0.5%
Q1 2017-4.7%-2.8%-10.1%
Q4 2016-1.6%-1.8%-0.4%
Q3 2016-14.6%
Q2 2016-2.0%
Q1 2016-12.1%
Q4 2015+25.2%
Q3 2015-3.4%
Q2 2015+1.2%
Q1 2015-1.7%
Q4 2014+11.3%
Q3 2014-0.1%
Q2 2014-5.6%
Q1 2014-0.3%
Q4 2013-4.9%
Q3 2013+0.5%
Q2 2013-0.7%
Q1 2013+7.5%
Q4 2010-2.9%
Q4 2012-2.9%
Q3 2012-0.3%
Q3 2011-0.3%
Q2 2011+2.5%
Q2 2012+2.5%
Q4 2011-7.3%
Q1 2011-7.3%
Q1 2012-7.3%
Q3 2010-0.5%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro